Well i have stayed away from this forum for a bit, as there is so much dribble going on. Though big shout out to the posters that give knowledgeable info. Anyway as has no doubt been discussed the bottleneck for MSB is the OTAT meeting. You would think if the FDA wanted MSB to progress quickly with a follow up covid trial then potency assays need to be defined hence urgency for the OTAT meeting?????????. Does anyway know or has SI indicated when this CRITICAL meeting is taking place??????. It really is mind blowing how slow the wheels of bureaucracy's such as the FDA move.
MSB Trading 2021 - paradigm shift, page-7759
-
- There are more pages in this discussion • 2,452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |